Top compounds associated with response to RP11-426L16.10


Feature Type Standardized
Nominal ANOVA
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.22 2e-08
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.22 2e-08
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.21 3e-08
mRNA barasertib CTRPv2 pan-cancer AAC -0.21 3e-08
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.22 3e-08
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.21 3e-08
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.21 4e-08
mRNA KPT185 CTRPv2 pan-cancer AAC -0.25 4e-08
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.22 4e-08
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 4e-08
Download CSV